Exact Mass: 562.3716784
Exact Mass Matches: 562.3716784
Found 454 metabolites which its exact mass value is equals to given mass value 562.3716784
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Rhodoxanthin
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
3-Hexaprenyl-4,5-Dihydroxybenzoic acid
3-Hexaprenyl-4,5-Dihydroxybenzoic acid is an intermediate in the biosynthesis of Ubiquinone. It is a substrate for Hexaprenyldihydroxybenzoate methyltransferase (mitochondrial). [HMDB] 3-Hexaprenyl-4,5-Dihydroxybenzoic acid is an intermediate in the biosynthesis of Ubiquinone. It is a substrate for Hexaprenyldihydroxybenzoate methyltransferase (mitochondrial).
Naquotinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
Cholesteryl ferulate
Cholesteryl ferulate is found in cereals and cereal products. Cholesteryl ferulate is a constituent of rice bran oil Constituent of rice bran oil. Cholesteryl ferulate is found in cereals and cereal products.
Cholesterol glucuronide
Cholesterol glucuronide is a natural human metabolite of Cholesterol generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Cholesterol glucuronide is a natural human metabolite of Cholesterol generated in the liver by UDP glucuonyltransferase.
Campesteryl caffeate
Campesteryl caffeate is found in cereals and cereal products. Campesteryl caffeate is a constituent of canary grass (Phalaris canariensis). Antioxidant Constituent of canary grass (Phalaris canariensis). Antioxidant. Campesteryl caffeate is found in cereals and cereal products.
Cucurbitacin IIa
1-(2-Azabicyclo[2.2.2]octan-2-yl)-2-[2-(3,5-dimethylphenyl)-3-[(2S)-1-(2-pyridin-2-ylethylamino)propan-2-yl]-1H-indol-5-yl]-2-methylpropan-1-one
Pinometostat
Tandutinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
5-alpha-Cholestane-3-beta,5,6-beta-triol, 6-acetate 3-(hydrogen succinate)
DG(10:0/PGJ2/0:0)
DG(10:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGJ2/10:0/0:0)
DG(PGJ2/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/PGJ2)
DG(10:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGJ2/0:0/10:0)
DG(PGJ2/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Cuc IIa
Cucurbitacin IIa is a natural product found in Hemsleya pengxianensis with data available. Cucurbitacin IIa is a triterpene isolated from Hemsleya amalils Diels, induces apoptosis of cancer cells, reduces expression of survivin, reduces phospho-Histone H3 and increases cleaved PARP in cancer cells[1]. Cucurbitacin IIa is a triterpene isolated from Hemsleya amalils Diels, induces apoptosis of cancer cells, reduces expression of survivin, reduces phospho-Histone H3 and increases cleaved PARP in cancer cells[1].
Dammarane-3,12,25-triol, 20,24-epoxy-, 3-(hydrogen propanedioate), (3.alpha.,12.beta.,24R)-
[5-hydroxy-1,1-dimethyl-4-oxo-5-(2,3,16-trihydroxy-4,4,9,13,14-pentamethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl)hexyl] acetate
Methyl 9,10,18-tris[(trimethylsilyl)oxy]octadecanoate #
(E)-15beta-O-(beta-D-xylopyranosyl)ergosta-5,22-diene-3beta,16beta-diol|acanthifolioside B
19-O-beta-D-glucopyranosyl-19-hydroxy-cholest-4-en-3-one
18-ethyloxy-17-hydroxy-17,18-dihydroscrobiculatone B
(3R,5aR,5bR,6R,7S,9S,11aR,12R,13bS)-icosahydro-7,9,12-trihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-1H-cyclopenta[a]chrysen-6-yl benzoate|7beta-(benzoyloxy)-21alphaH-24-norhopa-4(23),22(29)-diene-3beta,6beta,11alpha-triol|cavalerol D
18-ethyloxy-17-hydroxy-17,18-dihydroscrobiculatone A
Ile Phe Arg Lys
C27H46N8O5 (562.3590985999999)
Arg Ile Phe Lys
C27H46N8O5 (562.3590985999999)
Ile Gln Phe Arg
[(6R)-6-hydroxy-2-methyl-5-oxo-6-[(2S,3S,9R,13R,14S,16R)-2,3,16-trihydroxy-4,4,9,13,14-pentamethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]heptan-2-yl] acetate
(1R,2S,4R,5S,6S,11R,12R,14S,16R)-5,6,11-trihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-7-oxo-3-oxapentacyclo[9.5.0.0²,⁴.0⁶,¹⁰.0¹⁴,¹⁶]hexadec-8-en-14-yl dodecanoate
[(6R)-6-hydroxy-2-methyl-5-oxo-6-[(2S,3S,9R,13R,14S,16R)-2,3,16-trihydroxy-4,4,9,13,14-pentamethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]heptan-2-yl] acetate [IIN-based on: CCMSLIB00000848395]
[(6R)-6-hydroxy-2-methyl-5-oxo-6-[(2S,3S,9R,13R,14S,16R)-2,3,16-trihydroxy-4,4,9,13,14-pentamethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]heptan-2-yl] acetate [IIN-based: Match]
(3R,5R,6R,7S,9S,10R,13R,17R)-17-((R)-5-ethoxy-5-oxopentan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,6,7-triyl triacetate
Phe Ile Lys Arg
C27H46N8O5 (562.3590985999999)
Phe Ile Gln Arg
Phe Ile Arg Lys
C27H46N8O5 (562.3590985999999)
Phe Ile Arg Gln
Phe Lys Ile Arg
C27H46N8O5 (562.3590985999999)
Phe Lys Leu Arg
C27H46N8O5 (562.3590985999999)
Phe Lys Arg Ile
C27H46N8O5 (562.3590985999999)
Phe Lys Arg Leu
C27H46N8O5 (562.3590985999999)
Phe Leu Lys Arg
C27H46N8O5 (562.3590985999999)
Phe Leu Gln Arg
Phe Leu Arg Lys
C27H46N8O5 (562.3590985999999)
Phe Leu Arg Gln
Phe Gln Ile Arg
Phe Gln Leu Arg
Phe Gln Arg Ile
Phe Gln Arg Leu
Phe Arg Ile Lys
C27H46N8O5 (562.3590985999999)
Phe Arg Ile Gln
Phe Arg Lys Ile
C27H46N8O5 (562.3590985999999)
Phe Arg Lys Leu
C27H46N8O5 (562.3590985999999)
Phe Arg Leu Lys
C27H46N8O5 (562.3590985999999)
Phe Arg Leu Gln
Phe Arg Gln Ile
Phe Arg Gln Leu
Ile Phe Lys Arg
C27H46N8O5 (562.3590985999999)
Ile Phe Gln Arg
Ile Phe Arg Gln
Ile Lys Phe Arg
C27H46N8O5 (562.3590985999999)
Ile Lys Arg Phe
C27H46N8O5 (562.3590985999999)
Ile Gln Arg Phe
Ile Arg Phe Lys
C27H46N8O5 (562.3590985999999)
Ile Arg Phe Gln
Ile Arg Lys Phe
C27H46N8O5 (562.3590985999999)
Ile Arg Gln Phe
Lys Phe Ile Arg
C27H46N8O5 (562.3590985999999)
Lys Phe Leu Arg
C27H46N8O5 (562.3590985999999)
Lys Phe Arg Ile
C27H46N8O5 (562.3590985999999)
Lys Phe Arg Leu
C27H46N8O5 (562.3590985999999)
Lys Ile Phe Arg
C27H46N8O5 (562.3590985999999)
Lys Ile Arg Phe
C27H46N8O5 (562.3590985999999)
Lys Leu Phe Arg
C27H46N8O5 (562.3590985999999)
Lys Leu Arg Phe
C27H46N8O5 (562.3590985999999)
Lys Pro Arg Tyr
Lys Pro Tyr Arg
Lys Arg Phe Ile
C27H46N8O5 (562.3590985999999)
Lys Arg Phe Leu
C27H46N8O5 (562.3590985999999)
Lys Arg Ile Phe
C27H46N8O5 (562.3590985999999)
Lys Arg Leu Phe
C27H46N8O5 (562.3590985999999)
Lys Arg Pro Tyr
Lys Arg Tyr Pro
Lys Tyr Pro Arg
Lys Tyr Arg Pro
Leu Phe Lys Arg
C27H46N8O5 (562.3590985999999)
Leu Phe Gln Arg
Leu Phe Arg Lys
C27H46N8O5 (562.3590985999999)
Leu Phe Arg Gln
Leu Lys Phe Arg
C27H46N8O5 (562.3590985999999)
Leu Lys Arg Phe
C27H46N8O5 (562.3590985999999)
Leu Gln Phe Arg
Leu Gln Arg Phe
Leu Arg Phe Lys
C27H46N8O5 (562.3590985999999)
Leu Arg Phe Gln
Leu Arg Lys Phe
C27H46N8O5 (562.3590985999999)
Leu Arg Gln Phe
Pro Lys Arg Tyr
Pro Lys Tyr Arg
Pro Arg Lys Tyr
Pro Arg Tyr Lys
Pro Tyr Lys Arg
Pro Tyr Arg Lys
Gln Phe Ile Arg
Gln Phe Leu Arg
Gln Phe Arg Ile
Gln Phe Arg Leu
Gln Ile Phe Arg
Gln Ile Arg Phe
Gln Leu Phe Arg
Gln Leu Arg Phe
Gln Arg Phe Ile
Gln Arg Phe Leu
Gln Arg Ile Phe
Gln Arg Leu Phe
Arg Phe Ile Lys
C27H46N8O5 (562.3590985999999)
Arg Phe Ile Gln
Arg Phe Lys Ile
C27H46N8O5 (562.3590985999999)
Arg Phe Lys Leu
C27H46N8O5 (562.3590985999999)
Arg Phe Leu Lys
C27H46N8O5 (562.3590985999999)
Arg Phe Leu Gln
Arg Phe Gln Ile
Arg Phe Gln Leu
Arg Ile Phe Gln
Arg Ile Lys Phe
C27H46N8O5 (562.3590985999999)
Arg Ile Gln Phe
Arg Lys Phe Ile
C27H46N8O5 (562.3590985999999)
Arg Lys Phe Leu
C27H46N8O5 (562.3590985999999)
Arg Lys Ile Phe
C27H46N8O5 (562.3590985999999)
Arg Lys Leu Phe
C27H46N8O5 (562.3590985999999)
Arg Lys Pro Tyr
Arg Lys Tyr Pro
Arg Leu Phe Lys
C27H46N8O5 (562.3590985999999)
Arg Leu Phe Gln
Arg Leu Lys Phe
C27H46N8O5 (562.3590985999999)
Arg Leu Gln Phe
Arg Pro Lys Tyr
Arg Pro Tyr Lys
Arg Gln Phe Ile
Arg Gln Phe Leu
Arg Gln Ile Phe
Arg Gln Leu Phe
Arg Tyr Lys Pro
Arg Tyr Pro Lys
Tyr Lys Pro Arg
Tyr Lys Arg Pro
Tyr Pro Lys Arg
Tyr Pro Arg Lys
Tyr Arg Lys Pro
Tyr Arg Pro Lys
(5Z,7E)-(1S,3R)-11-(4-acetoxymethylphenyl)-9,10-seco-5,7,9(11),10(19)-cholestatetraene-1,3,25-triol
Campesteryl caffeate
Cholesteryl ferulate
11-(4-acetoxymethylphenyl)-1alpha,25-dihydroxy-9,11-didehydrovitamin D3
butyl 2-methylprop-2-enoate,butyl prop-2-enoate,ethylbenzene,methyl 2-methylprop-2-enoate,2-methylprop-2-enoic acid
Tandutinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
ESTRADIOL HEMIHYDRATE
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen
4-[[6-Acetyloxy-5-hydroxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid
1-(2-Azabicyclo[2.2.2]octan-2-yl)-2-[2-(3,5-dimethylphenyl)-3-[(2S)-1-(2-pyridin-2-ylethylamino)propan-2-yl]-1H-indol-5-yl]-2-methylpropan-1-one
[(1R,2S,4R,5S,6S,11R,12R,14S,16R)-5,6,11-Trihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-7-oxo-3-oxapentacyclo[9.5.0.02,4.06,10.014,16]hexadec-8-en-14-yl] dodecanoate
4-(dimethylamino)-N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide
4-(dimethylamino)-N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide
4-(dimethylamino)-N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide
4-(dimethylamino)-N-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide
4-(dimethylamino)-N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide
4-(dimethylamino)-N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide
4-(dimethylamino)-N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide
4-(dimethylamino)-N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide
4-(dimethylamino)-N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide
(3R,5R,6R,7S,9S,10R,13R,17R)-17-((R)-5-ethoxy-5-oxopentan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,6,7-triyl triacetate
[(6R)-6-hydroxy-2-methyl-5-oxo-6-[(2S,3S,9R,13R,14S,16R)-2,3,16-trihydroxy-4,4,9,13,14-pentamethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]heptan-2-yl] acetate
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate
[(E)-3-hydroxy-2-(pentadecanoylamino)non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(octanoylamino)hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(heptanoylamino)-3-hydroxyheptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(nonanoylamino)pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(hexadecanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(butanoylamino)-3-hydroxyicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(pentanoylamino)nonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(propanoylamino)henicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-acetamido-3-hydroxydocos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]nonyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(tetradecanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(tridecanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(dodecanoylamino)-3-hydroxydodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(decanoylamino)-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(undecanoylamino)tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]undecyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] hexadecanoate
[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] pentadecanoate
[1-Heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tridecanoate
[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] heptadecanoate
[1-Octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] dodecanoate
[1-Acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] octadecanoate
[1-Hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetradecanoate
[1-Nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] undecanoate
[2-Decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] decanoate
[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (Z)-icos-11-enoate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (Z)-henicos-11-enoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (Z)-nonadec-9-enoate
(1-acetyloxy-3-phosphonooxypropan-2-yl) (Z)-tetracos-13-enoate
(1-octanoyloxy-3-phosphonooxypropan-2-yl) (Z)-octadec-9-enoate
(1-butanoyloxy-3-phosphonooxypropan-2-yl) (Z)-docos-13-enoate
(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (Z)-heptadec-9-enoate
(1-decanoyloxy-3-phosphonooxypropan-2-yl) (Z)-hexadec-9-enoate
(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tetradec-9-enoate
(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (Z)-pentadec-9-enoate
[3-phosphonooxy-2-[(Z)-tridec-9-enoyl]oxypropyl] tridecanoate
N-(decanoyl)-4E-tetradecasphingenine-1-phosphocholine
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-hexadec-9-enoate
[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (E)-tetradec-9-enoate
[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxypropoxy]propyl]-trimethylazanium
[1-carboxy-3-[2-hydroxy-3-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxypropoxy]propyl]-trimethylazanium
[(2S)-2-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] decanoate
[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (E)-tetradec-9-enoate
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-pentadec-9-enoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-pentadec-9-enoate
[(E,2S,3R)-2-(decanoylamino)-3-hydroxytetradec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-hexadec-7-enoate
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-hexadec-7-enoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-hexadec-9-enoate
[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxypropoxy]propyl]-trimethylazanium
2-[[3-butanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C29H57NO7P+ (562.3872441999999)
[3-[3-butanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
2-[[3-acetyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[3-[3-acetyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
2-[hydroxy-[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
C29H57NO7P+ (562.3872441999999)
2-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C29H57NO7P+ (562.3872441999999)
2-[carboxy-[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-hydroxypropoxy]methoxy]ethyl-trimethylazanium
2-[[2-acetyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C29H57NO7P+ (562.3872441999999)
2-[[2-butanoyloxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C29H57NO7P+ (562.3872441999999)
3-Hexaprenyl-4,5-Dihydroxybenzoic acid
A dihydroxybenzoic acid where the hydroxy groups are at the 4- and 5-positions together with a hexaprenyl group at the 3-position.
1-dodecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphate
BisMePA(24:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
2-{[1-(5,6-dimethylhept-3-en-2-yl)-2,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3-yl]oxy}oxane-3,4,5-triol
(2s,4s)-n-[(3r,4r,7r,10z)-5,8-dihydroxy-3-isopropyl-7-[(1r)-1-phenylethyl]-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-4-methylhexanimidic acid
C33H46N4O4 (562.3518875999999)